Search Stock:
Natco Pharma Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Natco Pharma (NATCOPHARM (Bse Code: 524816)) Key Ratios
P/E
Company13.51
Sector7.4
A Price-to-Earnings of 13.51 means investors pay 13.51 units per 1 unit of earnings. This is higher than the sector average of 7.4.
P/B
Company1.68
Sector4.36
A P/B ratio of 1.68 shows market value relative to book value. This is lower than the sector average of 4.36.
ROA
Company9.16%
Sector-17.84%
Return on Assets shows a 9.16% profit per unit of asset. This is lower than the sector average of -17.84%.
ROE
Company15.38%
Sector-2.58%
Return on Equity creates 15.38% profit per unit of equity. This is higher than the sector average of -2.58%.
ROCE
Company15.37%
Sector6.43%
ROCE indicates 15.37% operating earnings per unit of capital. This is higher than the sector average of 6.43%.
EV/EBITDA
Company10.9
Sector14.92
EV/EBITDA of 10.9 means value is 10.9 times core earnings. This is lower than the sector average of 14.92.
Natco Pharma Share Price Analysis API (Live)
Natco Pharma share price is ₹853.80, day high (share price) is ₹861.00, day low (share price) is ₹844.85 and volume is 402,204. 52 Week high share price for Natco Pharma is ₹1,226.80 on 12 May 2026 and 52 week low share price for Natco Pharma is ₹789.00 on 30 Sep 2025. Price data as of: 28 Aug, 2026 3:31 PM.
According to latest price data (as of 28 Aug, 2026 3:31 PM) for Natco Pharma share, 14 day period RSI (Relative Strength Index) is 33.1, 50 DMA (50 Displaced Moving Average) is 920.60 and 200 DMA (200 Displaced Moving Average) is 944.81.
▼
₹853.80
-3.80 (-0.44%)
As of 28 Aug, 2026
Open
₹857.80
Day High - Low
₹861.00 - ₹844.85
Volume
402,204
52 Weeks High
₹1,226.80
on 12 May 2026
52 Weeks Low
₹789.00
on 30 Sep 2025
RSI (14)
33.1
50 DMA
920.60
200 DMA
944.81
Loading...
Natco Pharma (NATCOPHARM) Technical Analysis
₹853.80
-3.80
28 Aug, 2026
Natco Pharma Technical Data and Analysis available in multiple timeframes.
Natco Pharma Oscillators Analysis
On the Day timeframe, the outlook for NATCOPHARM is: The long-term trend is Negative (Price vs 200 SMA) and RSI (14) is: 33.1.
Natco Pharma Price Action
Natco Pharma Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 33.08 |
| Stoch %K (14, 3, 3) | 5.54 |
| CCI (20) | -146.20 |
| ADX (14) | 9.46 |
| Awesome Osc | -50.66 |
| Momentum (10) | -49.35 |
| MACD (12, 26, 9) | -19.34 |
| MACD Signal | -15.29 |
| Stoch RSI (14) | 0.00 |
| Williams %R (14) | -92.54 |
| Bull/Bear Power | -56.58 |
| Ultimate Osc | 29.68 |
| MFI (14) | 26.18 |
| ROC (21) | -8.18 |
| ROC (125) | -9.64 |
| ATR (14) | 24.25 |
Natco Pharma Moving Averages
NATCOPHARM is trading above 0 out of 14 SMAs.
853.80
CURRENT PRICE
Bullish Moving Averages
0
Bearish Moving Averages
14
5 SMA865.02
8 SMA871.48
9 SMA874.47
10 SMA876.00
12 SMA884.57
20 SMA897.02
21 SMA897.97
26 SMA903.73
30 SMA908.74
34 SMA915.16
50 SMA920.60
100 SMA989.86
150 SMA965.00
200 SMA944.81
| Ichimoku Base | 904.85 | Below Base |
| VWMA (20) | 901.29 | Below VWMA |
| HMA (9) | 853.11 | Above HMA |
Natco Pharma Technical SWOT Analysis
STRENGTHS
- No notable technical strength signals are currently observed.
WEAKNESSES
- Price is trading below the 200 DMA, indicating relatively weaker long-term structure.
- Price is below the 50 DMA, suggesting weaker medium-term positioning.
- MACD is below the signal line and in negative territory, reflecting downward momentum.
- RSI at 33.08 indicates weakening momentum.
OPPORTUNITIES
- Price is near the lower Bollinger Band, which can reflect either oversold conditions or continued downward pressure.
THREATS
- No immediate technical risk signals are identified.
Natco Pharma Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 877.73 | 882.03 | 858.24 | 869.37 |
| Resistance 2 | 869.37 | 871.51 | 856.76 | 863.20 |
| Resistance 1 | 861.58 | 865.88 | 855.28 | 859.39 |
| Pivot Point | 853.22 | 855.36 | 853.80 | 853.22 |
| Support 1 | 845.43 | 849.73 | 852.32 | 847.05 |
| Support 2 | 837.07 | 839.21 | 850.84 | 843.24 |
| Support 3 | 829.28 | 833.58 | 849.36 | 837.07 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Natco Pharma - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 49.42% | 49.42% | 49.48% | 49.48% |
| FII | 16.99% | 17.37% | 15.16% | 14.09% |
| DII (Other) | 3.70% | 3.74% | 3.79% | 3.68% |
| Retail & Others | 27.97% | 27.75% | 29.96% | 30.56% |
| Mutual Funds | 1.92% | 1.72% | 1.60% | 2.20% |
Natco Pharma - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 4,375.90 -8.53% | 1,490.80 -34.94% | 1,371.90 -27.16% |
| Mar 2025 | 4,784.00 +15.92% | 2,291.40 +36.92% | 1,883.40 +35.66% |
| Mar 2024 | 4,126.90 +46.78% | 1,673.50 +94.16% | 1,388.30 +94.09% |
| Mar 2023 | 2,811.70 | 861.90 | 715.30 |
Natco Pharma - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 20 Aug 2026 | ₹1.5 | View Details |
|
Announcement date
14 Aug 2026
Ex dividend date
20 Aug 2026
Record date
20 Aug 2026
Dividend type
Interim
Amount
1.5
Dividend %
75.0
Details
Rs.1.5000 per share(75%)Interim Dividend
|
|||
| Dividend | 18 Feb 2026 | ₹1.5 | View Details |
|
Announcement date
12 Feb 2026
Ex dividend date
18 Feb 2026
Record date
18 Feb 2026
Dividend type
Interim
Amount
1.5
Dividend %
75.0
Details
Rs.1.5000 per share(75%)Third Interim Dividend
|
|||
| Dividend | 20 Nov 2025 | ₹1.5 | View Details |
|
Announcement date
14 Nov 2025
Ex dividend date
20 Nov 2025
Record date
20 Nov 2025
Dividend type
Interim
Amount
1.5
Dividend %
75.0
Details
Rs.1.5000 per share(75%)Second Interim Dividend
|
|||
Natco Pharma Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...
